molecule-image-3

Medicinal Chemistry Powered by Machine Learning

PostEra is building a modern 21st century biopharma. We’re using our advances in machine learning to close the Design-Make-Test cycle of Medicinal Chemistry and bring more cures to patients.

molecule-image
molecule-image-2

Meet the Team

View All
Aaron_Morris_CEO

Aaron Morris

CEO

Alpha_Lee_CSO

Alpha Lee

CSO

Matthew_Robinson_CTO

Matthew Robinson

CTO

emily-ripka

Emily Ripka

Head of Product

Tony_Schroeder_ML_Researcher

Tony Schroeder

Head of Machine Learning

Our Drug Discovery Partners

molecule_bg_team
molecule-image

In the News

View All

May 2022

PostEra spearheads $68M collaboration to develop antivirals funded by the NIH

endpoint

Dec 2021

PostEra establishes $260M strategic AI Lab partnership with Pfizer and closes $24M in Series A financing

endpoint

Sep 2021

COVID Moonshot receives $11M grant from Wellcome Trust

DiamongLightSourceLtd2-COVIDMoonshot-CollaboratorsGroupShot-2021-scaled 2

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to close the Design-Make-Test cycle of medicinal chemistry and bring more cures to patients.

Stay up to date with our Newsletter

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to close the Design-Make-Test cycle of medicinal chemistry and bring more cures to patients.

Terms & Conditions

© 2022 PostEra